Watch the video & take notes on a sheet of paper
Once you have registered on Medscape, reach the page http://www.medscape.com/viewarticle/546111
When you have finished, click on each item below to see the answer.
Mark A. Wainberg, Twenty-Five Years of AIDS: Where Are We Now? – Medscape – Oct 27, 2006.
16th International Conference on AIDS in 2006
enormous progress (in the understanding & treatment options)
- 1981 (25 years before 2006 when the video commentary was recorded)
- MMWR (= Morbidity & Mortality Weekly Report of the CDC, Centers for Disease Control)
- around 1996
- highly active antiretroviral therapy (HAART)
- transformed HIV infection into a chronic, manageable condition in the rich countries in which these drugs are widely available
- but no change for Africa (> 20 million HIV-infected individuals will die unless they obtain access to these lifesaving medications)
- scientific advances that provide hope for the future
- 2 new classes of antiretroviral drugs (viral integrase inhibitors & entry inhibitors) ← excellent activity against all strains of HIV, including those that are resistant to all currently approved drugs
- integrase inhibitor → viral loads plummeted more sharply than has been seen with any antiretroviral drug studied to date
- entry inhibitors act by antagonizing cellular proteins; target a cellular component, rather than the virus directly → hope that resistance to these drugs will not easily develop
development of rapid saliva-based diagnostic assays to detect HIV infection
At present, the turnaround time for an antibody test is 3 weeks, and many people do not return to the clinic to obtain results
- Patients will receive antibody results while waiting in a doctor's office → no tortuous 3-week waiting period of older tests
- May also lead to a public health benefit
- good news in regard to both HIV therapeutics and diagnostics
- hope that political action will help ensure that these advances become available to people throughout the world
Demo Content